Statements (54)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:OSI_Pharmaceuticals
gptkb:Astellas_Pharma_US,_Inc. Ilypsa,_Inc. |
gptkbp:awards |
Various industry awards
|
gptkbp:clinicalTrials |
Conducts_clinical_trials_in_Canada
|
gptkbp:communityInvolvement |
Charitable donations
Health education initiatives Volunteer_programs |
gptkbp:corporateSocialResponsibility |
Sustainability initiatives
Patient support programs Community engagement programs |
gptkbp:employees |
Approximately 200
|
gptkbp:financialPerformance |
Sustainable business practices
Investment in R&D Strong revenue growth |
gptkbp:focus |
Immunology
Oncology Transplantation Urology Infectious diseases |
gptkbp:founded |
2005
|
gptkbp:globalPresence |
Operates in multiple countries
|
gptkbp:headquarters |
gptkb:Toronto,_Ontario,_Canada
|
https://www.w3.org/2000/01/rdf-schema#label |
Astellas Pharma Canada Inc.
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:innovation |
Focus on patient-centered solutions
|
gptkbp:investmentFocus |
Pharmaceutical research
Biotechnology companies Healthcare_technology. |
gptkbp:leadership |
Experienced management team
|
gptkbp:market |
gptkb:Canada
|
gptkbp:mission |
To improve the health of people around the world.
|
gptkbp:parentCompany |
gptkb:Astellas_Pharma_Inc.
|
gptkbp:partnerships |
Academic institutions
Research organizations Non-profit organizations Various healthcare organizations |
gptkbp:products |
Prescription medications
|
gptkbp:regulatoryCompliance |
gptkb:Health_Canada
|
gptkbp:research_areas |
Cardiology
Neurology Endocrinology Hematology Dermatology |
gptkbp:researchAndDevelopment |
Focus on innovative therapies
|
gptkbp:supplyChain |
Quality assurance standards
Sustainable logistics Ethical sourcing practices |
gptkbp:training |
Continuous professional development
Leadership development programs Diversity and inclusion training |
gptkbp:vision |
To be a trusted partner in healthcare.
|
gptkbp:website |
www.astellas.com/canada
|